ArticleCancers2026

Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study.

Orazio Caffo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.